Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

ClinicalTrials.gov ID: NCT02217475

Public ClinicalTrials.gov record NCT02217475. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether cenicriviroc is effective and safe in the treatment of nonalcoholic steatohepatitis (NASH) in adult participants with liver fibrosis.

Study identification

NCT ID
NCT02217475
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Tobira Therapeutics, Inc.
Industry
Enrollment
289 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 18, 2014 (Actual)
Primary completion
Jun 30, 2016 (Actual)
Completion
Jun 22, 2017 (Actual)
Last update posted
May 10, 2019

2014 – 2017

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
36
Facility City State ZIP Site status
Not listed Dothan Alabama 36305 —
Not listed Phoenix Arizona 85054 —
Not listed Tucson Arizona 85712 —
Not listed Rialto California 92377 —
Not listed San Diego California 92120 —
Not listed San Diego California 92161 —
Not listed San Francisco California 94115 —
Not listed Littleton Colorado 80120 —
Not listed Miami Florida 33136 —
Not listed Tampa Florida 33606 —
Not listed Chicago Illinois 60612 —
Not listed Louisville Kentucky 40202 —
Not listed New Orleans Louisiana 70112 —
Not listed Baltimore Maryland 21202 —
Not listed Baltimore Maryland 21287 —
Not listed Chevy Chase Maryland 20815 —
Not listed Lutherville Maryland 21093 —
Not listed Boston Massachusetts 02114 —
Not listed Worcester Massachusetts 01655 —
Not listed Ann Arbor Michigan 48109 —
Not listed Saint Paul Minnesota 55114 —
Not listed Flowood Mississippi 39232 —
Not listed Jackson Mississippi — —
Not listed Tupelo Mississippi 38801 —
Not listed Buffalo New York 14201 —
Not listed New York New York 10029 —
Not listed Durham North Carolina 27710 —
Not listed Raleigh North Carolina 27612 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Cincinnati Ohio 45249 —
Not listed Chattanooga Tennessee 37421 —
Not listed Germantown Tennessee 38138 —
Not listed Houston Texas 77030 —
Not listed Houston Texas 78234 —
Not listed Live Oak Texas 78233 —
Not listed San Antonio Texas 78215 —
Not listed San Antonio Texas 78233 —
Not listed Salt Lake City Utah 84132 —
Not listed Richmond Virginia 23298 —
Not listed Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02217475, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2019 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02217475 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →